Xingxing Diao

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Benign Prostatic Hyperplasia

Crystal Structure

High Throughput

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yaoliang Sun, Manman Chen, Yuyan Han, Weiqiang Li, Xiaoyu Ma, Zihan Shi, Yang Zhou, Lan Xu, Lei Yu, Yuxiang Wang, Jinghua Yu, Xingxing Diao, Linghua Meng, Shilin Xu
Discovery of Pyrido[2,3- d ]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment. Journal of medicinal chemistry (2024)
Yaoliang Sun, Manman Chen, Yuyan Han, Weiqiang Li, Xiaoyu Ma, Zihan Shi, Yang Zhou, Lan Xu, Lei Yu, Yuxiang Wang, Jinghua Yu, Xingxing Diao, Linghua Meng, Shilin Xu
Discovery of Pyrido[2,3- d ]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment. Journal of medicinal chemistry 67 (5) (2024)
Yifei He, Yuandong Zheng, Chenggu Zhu, Peng Lei, Jinghua Yu, Chongzhuang Tang, Hao Chen, Xingxing Diao
Radioactive ADME Demonstrates ARV-110's High Druggability Despite Low Oral Bioavailability. Journal of medicinal chemistry (2024)
Yifei He, Yuandong Zheng, Chenggu Zhu, Peng Lei, Jinghua Yu, Chongzhuang Tang, Hao Chen, Xingxing Diao
Radioactive ADME Demonstrates ARV-110's High Druggability Despite Low Oral Bioavailability. Journal of medicinal chemistry 67 (16) (2024)
Yaoliang Sun, Manman Chen, Yuyan Han, Weiqiang Li, Xiaoyu Ma, Zihan Shi, Yang Zhou, Lan Xu, Lei Yu, Yuxiang Wang, Jinghua Yu, Xingxing Diao, Linghua Meng, Shilin Xu
Discovery of Pyrido[2,3- d ]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment. Journal of medicinal chemistry 67 (5) (2024)
Wen-Jing Wang, Lixin Gao, Simei Wang, Wensi Huang, Xin-Yu Meng, Hao Hu, Ziqiang Chen, Jingya Sun, Yali Yuan, Yubo Zhou, Xingxing Diao, Ruimin Huang, Jia Li, Xiao-Hua Chen
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (12) (2024)
Wen-Jing Wang, Lixin Gao, Simei Wang, Wensi Huang, Xin-Yu Meng, Hao Hu, Ziqiang Chen, Jingya Sun, Yali Yuan, Yubo Zhou, Xingxing Diao, Ruimin Huang, Jia Li, Xiao-Hua Chen
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer. Journal of medicinal chemistry (2024)
Wen-Jing Wang, Lixin Gao, Simei Wang, Wensi Huang, Xin-Yu Meng, Hao Hu, Ziqiang Chen, Jingya Sun, Yali Yuan, Yubo Zhou, Xingxing Diao, Ruimin Huang, Jia Li, Xiao-Hua Chen
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (12) (2024)
Yifei He, Yuandong Zheng, Chenggu Zhu, Peng Lei, Jinghua Yu, Chongzhuang Tang, Hao Chen, Xingxing Diao
Radioactive ADME Demonstrates ARV-110's High Druggability Despite Low Oral Bioavailability. Journal of medicinal chemistry 67 (16) (2024)
Cheng Yang, Mingzhen Xue, Yifei He, Hanwei Yin, Chen Yang, Dafang Zhong, Huihui Zeng, Yuandong Zheng, Xingxing Diao
Absorption, Distribution, Metabolism, and Excretion of [ 14 C]BS1801, a Selenium-Containing Drug Candidate, in Rats. Molecules (Basel, Switzerland) 28 (24) (2023)
Cheng Yang, Mingzhen Xue, Yifei He, Hanwei Yin, Chen Yang, Dafang Zhong, Huihui Zeng, Yuandong Zheng, Xingxing Diao
Absorption, Distribution, Metabolism, and Excretion of [ 14 C]BS1801, a Selenium-Containing Drug Candidate, in Rats. Molecules (Basel, Switzerland) 28 (24) (2023)
Danni Rao, Tao Yang, Huixu Feng, Qi An, Shaofeng Zhang, Jinghua Yu, Xuelian Ren, Xingxing Diao, He Huang, Wei Tang, Shilin Xu
Discovery and Structural Optimization of Covalent ZAP-70 Kinase Inhibitors against Psoriasis. Journal of medicinal chemistry (2023)
Chuan Zhou, Zisheng Fan, Zehui Zhou, Yupeng Li, Rongrong Cui, Chaoyi Liu, Guizhen Zhou, Xingxing Diao, Hualiang Jiang, Mingyue Zheng, Sulin Zhang, Tianfeng Xu
Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. Journal of medicinal chemistry 65 (5) (2022)
Jeremy Carlier, Xingxing Diao, Raffaele Giorgetti, Francesco P Busardò, Marilyn A Huestis
Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations. International journal of molecular sciences 22 (1) (2020)